Related references
Note: Only part of the references are listed.Endometrial Adenocarcinoma: Clinicopathologic and Survival Characteristics in Yazd, Iran
Fariba Binesh et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Comparison of Crude and Age-Specific Incidence Rates of Breast, Ovary, Endometrium and Cervix Cancers in Iran, 2005
Maliheh Arab et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Expression and Effects of JMJD2A Histone Demethylase in Endometrial Carcinoma
Hong-Li Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Polycystic Ovary Syndrome
Anindita Nandi et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2014)
Long-Term Estradiot Exposure Is a Direct Mitogen for Insulin/EGF-Primed Endometriat Cells and Drives PTEN Loss-Induced Hyperplasic Growth
Nuria Eritja et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer
Masa Sinreih et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): Time for paradigm shift?
Mohamad N. Shafiee et al.
GYNECOLOGIC ONCOLOGY (2013)
Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells
Kavita S. Subramaniam et al.
PLOS ONE (2013)
Cancer risk and PCOS
Daniel A. Dumesic et al.
STEROIDS (2013)
Body mass index does not influence post-treatment survival in early stage endometrial cancer: Results from the MRC ASTEC trial
Emma J. Crosbie et al.
EUROPEAN JOURNAL OF CANCER (2012)
Insulin resistance: A significant risk factor of endometrial cancer
Nan Mu et al.
GYNECOLOGIC ONCOLOGY (2012)
Evaluating the association between endometrial cancer and polycystic ovary syndrome
Zeina Haoula et al.
HUMAN REPRODUCTION (2012)
Hormone therapy for younger patients with endometrial cancer
Wen-Ling Lee et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2012)
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Mark O. Goodarzi et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Progesterone: the ultimate endometrial tumor suppressor
Shujie Yang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2011)
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
H. Teede et al.
BMC MEDICINE (2010)
Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study
Emily J. Fearnley et al.
CANCER CAUSES & CONTROL (2010)
Role of Progesterone in Endometrial Cancer
J. Julie Kim et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives
Zong-Qi Shen et al.
OBSTETRICS AND GYNECOLOGY (2008)
Diagnostic criteria for polycystic ovarian syndrome
F. J. Broekmans et al.
ENDOCRINE (2006)
Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome
S Quezada et al.
FERTILITY AND STERILITY (2006)
The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome
HF Escobar-Morreale et al.
ENDOCRINE REVIEWS (2005)
Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways
RB Lathi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways
S Kato et al.
GENES TO CELLS (2000)
Follicular dynamics in the polycystic ovary syndrome
S Franks et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2000)
Share Paper
